Macrophage Activation Syndrome (MAS): A Case Report and Narrative Review.

adult-onset still’s disease adult-onset still’s disease (aosd) hemophagocytic lymphohistiocytosis hemophagocytic lymphohistiocytosis (hlh) macrophage activation syndrome macrophage activation syndrome (mas) sepsis uti

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Mar 2023
Historique:
accepted: 01 03 2023
medline: 5 4 2023
entrez: 4 4 2023
pubmed: 5 4 2023
Statut: epublish

Résumé

Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening syndrome of excessive inflammation and tissue destruction secondary to abnormal immune activation. The term macrophage activation syndrome (MAS) is used when HLH develops in the setting of systemic juvenile idiopathic arthritis (SJIA; formerly known as Still's disease), adult-onset Still's disease, or any other rheumatologic disorder. We present a case of a 21-year-old female with a known history of SJIA who presented to the hospital with fever, chills, myalgia, nausea, vomiting, and hypotension. Initial evaluation at the time of presentation suggested sepsis likely due to acute pyelonephritis, and the patient was started on antibiotics and intravenous fluid hydration. However, further workup suggested that her symptoms were non-infectious and were likely due to MAS, a rare complication of SJIA. We promptly diagnosed her, and she received a course of steroids and made an uneventful recovery.

Identifiants

pubmed: 37012949
doi: 10.7759/cureus.35670
pmc: PMC10065992
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e35670

Informations de copyright

Copyright © 2023, Dilibe et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Clin Rheumatol. 2020 Aug;39(8):2379-2386
pubmed: 32130578
Rev Med Interne. 2015 May;36(5):319-27
pubmed: 25466605
J Formos Med Assoc. 2010 Jan;109(1):85-8
pubmed: 20123591
Paediatr Drugs. 2020 Feb;22(1):29-44
pubmed: 31732958
Pediatr Blood Cancer. 2007 Feb;48(2):124-31
pubmed: 16937360
Nat Rev Rheumatol. 2016 May;12(5):259-68
pubmed: 27009539
Clin Rheumatol. 2016 May;35(5):1145-51
pubmed: 26809798
Blood. 2011 Oct 13;118(15):4041-52
pubmed: 21828139
Arch Pathol Lab Med. 2022 Apr 1;146(4):507-519
pubmed: 34347856
Blood Rev. 2016 Nov;30(6):411-420
pubmed: 27238576
Rheumatol Int. 2021 Jan;41(1):7-18
pubmed: 32588191
Blood. 2019 Jun 6;133(23):2465-2477
pubmed: 30992265
J Rheumatol. 1992 Mar;19(3):424-30
pubmed: 1578458
Case Rep Med. 2016;2016:2071815
pubmed: 27847518
Cureus. 2020 Oct 24;12(10):e11139
pubmed: 33240728
Cureus. 2021 Sep 17;13(9):e18037
pubmed: 34671525

Auteurs

Arthur Dilibe (A)

Internal Medicine, Brody School of Medicine at East Carolina University, Greenville, USA.

Onyinye S Ugoala (OS)

Internal Medicine, College of Medicine, University of Lagos, Lagos, NGA.

Endurance O Evbayekha (EO)

Internal Medicine, St. Luke's Hospital, Chesterfield, USA.

Mohammad Z Khalilullah (MZ)

Internal Medicine, Brody School of Medicine at East Carolina University, Greenville, USA.

Olanrewaju K Adabale (OK)

Internal Medicine, Brody School of Medicine at East Carolina University, Greenville, USA.

Tracy-Ann Poyser (TA)

Internal Medicine, Unity Health White County Medical Center, Searcy, USA.

Osejie F Oriaifo (OF)

Internal Medicine, Brody School of Medicine at East Carolina University, Greenville, USA.

Ufuoma I Olori (UI)

Internal Medicine, Jersey City Medical Center, Jersey City, USA.

Henry O Aiwuyo (HO)

Internal Medicine, Brookdale University Hospital Medical Center, Brooklyn, USA.

Classifications MeSH